Previous Section Index Home Page


Miss Kirkbride: To ask the Secretary of State for Health how many people contracted (a) measles, (b) mumps and (c) rubella in each of the last five years. [32981]

Yvette Cooper: The number of confirmed cases of measles, mumps and rubella between 1996 and 2000 are shown in the table. The data for 2001 are provisional and are therefore subject to change.


(90) Provisional data

Mr. Andrew Turner: To ask the Secretary of State for Health when the single measles vaccine ceased to be available on the national health service; and for what reason it was withdrawn. [34357]

Yvette Cooper [holding answer 7 February 2002]: Measles vaccine was replaced with MMR from October 1988. Since then each of the manufacturers have advised the Department that they no longer intended to supply single measles vaccine to the United Kingdom.

Tim Loughton: To ask the Secretary of State for Health what figures he has collected for MMR vaccination rates in the October to December 2001 quarter in the UK, broken down by health authority area. [34877]

Yvette Cooper [holding answer 11 February 2002]: The information requested is not yet available.

When published the information about coverage rates by region for children who have received a primary MMR vaccination by their second birthday and a booster vaccination by age five is contained in the Statistical Bulletin "NHS Immunisation Statistics,

25 Feb 2002 : Column 950W

England: 2000/01". A copy of the bulletin will be placed in the Library and can also be found on the Department of Health website

Miss Kirkbride: To ask the Secretary of State for Health what information he has collated on the countries in the EU which license single vaccinations for measles, mumps and rubella. [35423]

Yvette Cooper: We do not keep a database of single component MMR vaccines licensed in European Union member states. However, all EU member states recommend a two dose vaccination schedule with MMR vaccine. None routinely recommend single vaccines instead of MMR.

There is no comprehensive list available of measles, mumps and rubella combination vaccines, two-component vaccines or single component vaccines that are currently licensed in Europe . The Medicines Control Agency has obtained the following information from "The European Drug Index" (1997 edition), from national compendia of licensed medicinal products in France, Germany, Switzerland and Sweden (1998 to 2000 editions), and from two companies. While these references indicate that such products are currently licensed as listed in the named countries, it is not known whether or not they are on the market at the present time.

In the EU and Switzerland

Mr. Andrew Turner: To ask the Secretary of State for Health what information he collects on the number of children who have received single measles, mumps and rubella inoculations since the introduction of the triple MMR vaccine (a) privately and (b) on the national health service. [34496]

Yvette Cooper: From the information collected it is not possible to distinguish whether vaccinations were done privately or on the national health service.

Patient Malnutrition

Mr. Burstow: To ask the Secretary of State for Health what statistics his Department collects concerning (a) (i) primary and (ii) contributory diagnosis relating to malnutrition and (b) the weight of patients on (1) admission and (2) discharge from hospital by age. [32624]

Yvette Cooper [holding answer 4 February 2002]: The Department collects information on in-patients as part of the hospital episodes statistics (HES) system, which contains details of patients admitted to and treated in

25 Feb 2002 : Column 951W

National Health Service hospitals in England. HES records contain up to seven diagnoses (coded to ICD10 where malnutrition is E40 to E46). The first of these is the main reason that the patient was in hospital; any

25 Feb 2002 : Column 952W

subsidiary or secondary diagnoses are recorded in the last six fields. Admissions to hospital with a main diagnosis of malnutrition, by age, are given in the table.

No data are held on the weight of the patient.

Admissions to NHS hospitals in England where the patient's main diagnosis was malnutrition

85 and over352731222427
Not Known000000


Admissions are defined as the first period of patient care under one consultant within one healthcare provider. Please note that admissions do not represent the number of patients, as a person may have more than one admission within the year. Figures have not yet been adjusted for shortfalls in data (i.e. the data is ungrossed).


Hospital Episode Statistics (HES), Department of Health.

Disabled Parking

Dr. Fox: To ask the Secretary of State for Health what guidance he has issued on the level of minimum provision of disabled parking spaces at NHS hospitals. [33497]

Mr. Hutton: National Health Service Estates, an executive agency of the Department of Health, provides advice and guidance to the NHS, principally through a series of documents. These represent best practice guidance, and through their adoption, NHS trusts and health authorities should comply with current legislation affecting disabled people.

NHS Estates guidance document "Car Parking" (1996—Health Facilities Note 21) suggests overall proportion of car park spaces for disabled people for healthcare premises, whilst accepting that the number and different types of car park spaces would be dependent on the range of healthcare services and facilities provided.

The Department also issued "Doubly Disabled—Equality for Disabled People in the new NHS—Access to Services" (1999). This guidance gives advice on accessibility for disabled people including 'Transport, cars and parking'. To help underpin this process, an access audit tool was developed and made available to all NHS bodies in 1999.

Angiogram Assessment

Mr. Laurence Robertson: To ask the Secretary of State for Health if he will make a statement on the waiting lists for angiogram assessment in (a) England and (b) Gloucestershire. [33056]

Mr. Hutton: [holding answer 4 February 2002]: Data are not collected on the number of patients waiting for angiograms. On the 21 November 2001, we announced details of the first wave of £65 million of New Opportunities Fund money which will provide new angiography equipment at 37 hospitals. This was matched by £15 million from the Treasury Capital Modernisation Fund to be used on building laboratory facilities for angiography at 22 hospitals. Further Treasury Capital Modernisation Fund money for buildings will follow to match second and third wave New Opportunities Fund funding. This first wave of funding will enable the National Health Service to carry out an extra 14,000 angiograms each year, and so reduce waiting times.

Walsgrave Hospital

Mr. Jim Cunningham: To ask the Secretary of State for Health why the announcement of the CHI Progress report into the investigation of the Walsgrave Hospital has been postponed. [32657]

Yvette Cooper: [holding answer 5 February 2002]: A Commission for Health Improvement team revisited University Hospitals Coventry and Warwickshire NHS Trust, which includes Walsgrave General Hospital, to assess progress in implementing the trust's action plan, following a clinical governance review last year. The visit took place on 22–23 January 2002, and a report is due to be published in March 2002.

Next Section Index Home Page